Mesa Laboratories Inc (MLAB) - Total Assets
Based on the latest financial reports, Mesa Laboratories Inc (MLAB) holds total assets worth $434.85 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mesa Laboratories Inc - Total Assets Trend (1988–2025)
This chart illustrates how Mesa Laboratories Inc's total assets have evolved over time, based on quarterly financial data. Also see market cap of Mesa Laboratories Inc for the company's overall valuation and market capitalisation.
Mesa Laboratories Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
Mesa Laboratories Inc's total assets of $434.85 Million consist of 23.7% current assets and 76.3% non-current assets. Review Mesa Laboratories Inc total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.3% |
| Accounts Receivable | $41.97 Million | 9.7% |
| Inventory | $25.36 Million | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $96.88 Million | 22.4% |
| Goodwill | $181.76 Million | 41.9% |
Asset Composition Trend (1988–2025)
This chart illustrates how Mesa Laboratories Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Mesa Laboratories Inc share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mesa Laboratories Inc's current assets represent 23.7% of total assets in 2025, a decrease from 100.0% in 1988.
- Cash Position: Cash and equivalents constituted 6.3% of total assets in 2025, down from 66.7% in 1988.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 0.0% in 1988.
- Asset Diversification: The largest asset category is goodwill at 41.9% of total assets.
Mesa Laboratories Inc Competitors by Total Assets
Key competitors of Mesa Laboratories Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Siglent Technologies Co Ltd
SHG:688112
|
China | CN¥1.70 Billion |
|
Focused Photonics Hangzhou Inc
SHE:300203
|
China | CN¥8.67 Billion |
|
Goldcard High-Tech Co Ltd
SHE:300349
|
China | CN¥7.43 Billion |
|
HyVision System. Inc
KQ:126700
|
Korea | ₩335.99 Billion |
|
X2M Connect Ltd
AU:X2M
|
Australia | AU$4.78 Million |
|
Satis Group S.A.
WAR:STS
|
Poland | zł2.37 Million |
|
Codan Ltd
AU:CDA
|
Australia | AU$912.27 Million |
|
Catapult Group International Ltd
AU:CAT
|
Australia | AU$218.31 Million |
Mesa Laboratories Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | 0.71 | 9.32 |
| Quick Ratio | 1.45 | 0.53 | 8.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $51.24 Million | $-45.03 Million | $271.17 Million |
Mesa Laboratories Inc - Advanced Valuation Insights
This section examines the relationship between Mesa Laboratories Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.14 |
| Latest Market Cap to Assets Ratio | 1.33 |
| Asset Growth Rate (YoY) | -3.0% |
| Total Assets | $433.35 Million |
| Market Capitalization | $578.17 Million USD |
Valuation Analysis
Above Book Valuation: The market values Mesa Laboratories Inc's assets above their book value (1.33x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Mesa Laboratories Inc's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Mesa Laboratories Inc (1988–2025)
The table below shows the annual total assets of Mesa Laboratories Inc from 1988 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $433.35 Million | -3.01% |
| 2024-03-31 | $446.80 Million | -32.49% |
| 2023-03-31 | $661.83 Million | -6.44% |
| 2022-03-31 | $707.37 Million | +17.61% |
| 2021-03-31 | $601.48 Million | +43.14% |
| 2020-03-31 | $420.21 Million | +168.04% |
| 2019-03-31 | $156.77 Million | -4.47% |
| 2018-03-31 | $164.10 Million | -4.44% |
| 2017-03-31 | $171.73 Million | +6.83% |
| 2016-03-31 | $160.75 Million | +37.02% |
| 2015-03-31 | $117.32 Million | +20.29% |
| 2014-03-31 | $97.53 Million | +47.95% |
| 2013-03-31 | $65.92 Million | +30.03% |
| 2012-03-31 | $50.70 Million | -0.56% |
| 2011-03-31 | $50.98 Million | +51.56% |
| 2010-03-31 | $33.64 Million | +13.59% |
| 2009-03-31 | $29.61 Million | +15.98% |
| 2008-03-31 | $25.53 Million | +14.22% |
| 2007-03-31 | $22.35 Million | +35.89% |
| 2006-03-31 | $16.45 Million | -0.88% |
| 2005-03-31 | $16.60 Million | +2.26% |
| 2004-03-31 | $16.23 Million | +7.06% |
| 2003-03-31 | $15.16 Million | +5.01% |
| 2002-03-31 | $14.44 Million | +4.47% |
| 2001-03-31 | $13.82 Million | +2.10% |
| 2000-03-31 | $13.53 Million | +7.41% |
| 1999-03-31 | $12.60 Million | +6.78% |
| 1998-03-31 | $11.80 Million | +15.69% |
| 1997-03-31 | $10.20 Million | +15.91% |
| 1996-03-31 | $8.80 Million | +27.54% |
| 1995-03-31 | $6.90 Million | +13.11% |
| 1994-03-31 | $6.10 Million | +12.96% |
| 1993-03-31 | $5.40 Million | +31.71% |
| 1992-03-31 | $4.10 Million | +28.13% |
| 1991-03-31 | $3.20 Million | +28.00% |
| 1990-03-31 | $2.50 Million | +78.57% |
| 1989-03-31 | $1.40 Million | +16.67% |
| 1988-03-31 | $1.20 Million | -- |
About Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and clean… Read more